• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可变糖基化MUC1抗原-抗体结合的比较配体结构分析

Comparative ligand structural analytics illustrated on variably glycosylated MUC1 antigen-antibody binding.

作者信息

Barnett Christopher B, Senapathi Tharindu, Naidoo Kevin J

机构信息

Scientific Computing Research Unit and Department of Chemistry, University of Cape Town, Rondebosch, 7701, South Africa.

Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Rondebosch, 7701, South Africa.

出版信息

Beilstein J Org Chem. 2020 Oct 13;16:2540-2550. doi: 10.3762/bjoc.16.206. eCollection 2020.

DOI:10.3762/bjoc.16.206
PMID:33133286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7590620/
Abstract

When faced with the investigation of the preferential binding of a series of ligands against a known target, the solution is not always evident from single structure analysis. An ensemble of structures generated from computer simulations is valuable; however, visual analysis of the extensive structural data can be overwhelming. Rapid analysis of trajectory data, with tools available in the Galaxy platform, can be used to understand key features and compare differences that inform the preferential ligand structure that favors binding. We illustrate this informatics approach by investigating the in-silico binding of a peptide and glycopeptide epitope of the glycoprotein Mucin 1 (MUC1) binding with the antibody AR20.5. To study the binding, we performed molecular dynamics simulations using OpenMM and then used the Galaxy platform for data analysis. The same analysis tools are applied to each of the simulation trajectories and this process was streamlined by using Galaxy workflows. The conformations of the antigens were analyzed using root-mean-square deviation, end-to-end distance, Ramachandran plots, and hydrogen bonding analysis. Additionally, RMSF and clustering analysis were carried out. These analyses were used to rapidly assess key features of the system, interrogate the dynamic structure of the ligand, and determine the role of glycosylation on the conformational equilibrium. The glycopeptide conformations in solution change relative to the peptide; thus a partially pre-structuring is seen prior to binding. Although the bound conformation of peptide and glycopeptide is similar, the glycopeptide fluctuates less and resides in specific conformers for more extended periods. This structural analysis which gives a high-level view of the features in the system under observation, could be readily applied to other binding problems as part of a general strategy in drug design or mechanistic analysis.

摘要

当面临一系列配体与已知靶点的优先结合情况的研究时,仅通过单一结构分析往往无法明确解决方案。通过计算机模拟生成的一组结构很有价值;然而,对大量结构数据进行可视化分析可能会让人应接不暇。利用Galaxy平台中可用的工具对轨迹数据进行快速分析,可用于了解关键特征并比较差异,从而为有利于结合的优先配体结构提供信息。我们通过研究糖蛋白粘蛋白1(MUC1)的肽和糖肽表位与抗体AR20.5的计算机模拟结合情况,来说明这种信息学方法。为了研究这种结合,我们使用OpenMM进行了分子动力学模拟,然后使用Galaxy平台进行数据分析。将相同的分析工具应用于每个模拟轨迹,并通过使用Galaxy工作流程简化了这一过程。使用均方根偏差、端到端距离、拉氏图和氢键分析对抗原的构象进行了分析。此外,还进行了均方根波动(RMSF)和聚类分析。这些分析用于快速评估系统的关键特征,探究配体的动态结构,并确定糖基化对构象平衡的作用。溶液中的糖肽构象相对于肽会发生变化;因此在结合之前可以看到部分预构象。尽管肽和糖肽的结合构象相似,但糖肽的波动较小,并且在特定构象中停留的时间更长。这种能对观察到的系统特征进行高层次观察的结构分析,作为药物设计或机理分析的一般策略的一部分,可以很容易地应用于其他结合问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0d3/7590620/2ca1bd82a659/Beilstein_J_Org_Chem-16-2540-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0d3/7590620/3a49fb7500aa/Beilstein_J_Org_Chem-16-2540-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0d3/7590620/a87e7ff1f18d/Beilstein_J_Org_Chem-16-2540-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0d3/7590620/f0c21e37cded/Beilstein_J_Org_Chem-16-2540-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0d3/7590620/a91959e1a46c/Beilstein_J_Org_Chem-16-2540-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0d3/7590620/2ca1bd82a659/Beilstein_J_Org_Chem-16-2540-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0d3/7590620/3a49fb7500aa/Beilstein_J_Org_Chem-16-2540-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0d3/7590620/a87e7ff1f18d/Beilstein_J_Org_Chem-16-2540-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0d3/7590620/f0c21e37cded/Beilstein_J_Org_Chem-16-2540-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0d3/7590620/a91959e1a46c/Beilstein_J_Org_Chem-16-2540-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0d3/7590620/2ca1bd82a659/Beilstein_J_Org_Chem-16-2540-g006.jpg

相似文献

1
Comparative ligand structural analytics illustrated on variably glycosylated MUC1 antigen-antibody binding.可变糖基化MUC1抗原-抗体结合的比较配体结构分析
Beilstein J Org Chem. 2020 Oct 13;16:2540-2550. doi: 10.3762/bjoc.16.206. eCollection 2020.
2
Glycosylation of MUC1 influences the binding of a therapeutic antibody by altering the conformational equilibrium of the antigen.MUC1 的糖基化通过改变抗原的构象平衡来影响治疗性抗体的结合。
Glycobiology. 2017 Jul 1;27(7):677-687. doi: 10.1093/glycob/cww131.
3
Role of glycosylation on the ensemble of conformations in the MUC1 immunodominant epitope.糖基化在 MUC1 免疫显性表位构象总体中的作用。
J Pept Sci. 2020 Jan;26(1):e3229. doi: 10.1002/psc.3229. Epub 2019 Nov 14.
4
Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.抗MUC1单克隆抗体C595与合成的MUC1粘蛋白核心相关肽及糖肽的结构/活性研究
Biospectroscopy. 1999;5(2):79-91. doi: 10.1002/(SICI)1520-6343(1999)5:2<79::AID-BSPY2>3.0.CO;2-#.
5
Structural effects of O-glycosylation on a 15-residue peptide from the mucin (MUC1) core protein.O-糖基化对粘蛋白(MUC1)核心蛋白中一个15残基肽段的结构影响。
Biochemistry. 2000 Oct 3;39(39):12076-82. doi: 10.1021/bi0010120.
6
Probing the conformational and dynamical effects of O-glycosylation within the immunodominant region of a MUC1 peptide tumor antigen.探究O-糖基化对MUC1肽肿瘤抗原免疫显性区域构象和动力学的影响。
J Pept Res. 2003 Mar;61(3):91-108. doi: 10.1034/j.1399-3011.2003.00031.x.
7
Effect of glycosylation on MUC1 humoral immune recognition: NMR studies of MUC1 glycopeptide-antibody interactions.糖基化对MUC1体液免疫识别的影响:MUC1糖肽-抗体相互作用的核磁共振研究
Biochemistry. 2002 Aug 6;41(31):9946-61. doi: 10.1021/bi012176z.
8
Structure-Based Design of Potent Tumor-Associated Antigens: Modulation of Peptide Presentation by Single-Atom O/S or O/Se Substitutions at the Glycosidic Linkage.基于结构的强效肿瘤相关抗原设计:通过糖苷键处的单原子 O/S 或 O/Se 取代来调节肽呈递。
J Am Chem Soc. 2019 Mar 6;141(9):4063-4072. doi: 10.1021/jacs.8b13503. Epub 2019 Feb 20.
9
Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy.抗体晶体学揭示的癌症中 MUC1 串联重复序列表位:朝着糖肽特征指导的治疗。
Molecules. 2018 May 31;23(6):1326. doi: 10.3390/molecules23061326.
10
Structurally defined synthetic cancer vaccines: analysis of structure, glycosylation and recognition of cancer associated mucin, MUC-1 derived peptides.结构明确的合成癌症疫苗:癌症相关粘蛋白MUC-1衍生肽的结构、糖基化及识别分析
Glycoconj J. 1995 Oct;12(5):607-17. doi: 10.1007/BF00731254.

引用本文的文献

1
GlycoBioinformatics.糖生物信息学
Beilstein J Org Chem. 2021 Nov 9;17:2726-2728. doi: 10.3762/bjoc.17.184. eCollection 2021.
2
Mucins as anti-cancer targets: perspectives of the glycobiologist.黏蛋白作为抗癌靶点:糖生物学家的观点。
Glycoconj J. 2021 Aug;38(4):459-474. doi: 10.1007/s10719-021-09986-8. Epub 2021 Mar 11.

本文引用的文献

1
The ChemicalToolbox: reproducible, user-friendly cheminformatics analysis on the Galaxy platform.化学工具箱:在Galaxy平台上进行可重复、用户友好的化学信息学分析。
J Cheminform. 2020 Jun 1;12(1):40. doi: 10.1186/s13321-020-00442-7.
2
Glycosylator: a Python framework for the rapid modeling of glycans.糖基化酶:用于糖链快速建模的 Python 框架。
BMC Bioinformatics. 2019 Oct 22;20(1):513. doi: 10.1186/s12859-019-3097-6.
3
The Galaxy Platform for Reproducible Affinity Proteomic Mass Spectrometry Data Analysis.用于可重复亲和蛋白质组质谱数据分析的银河平台。
Methods Mol Biol. 2019;1977:249-261. doi: 10.1007/978-1-4939-9232-4_16.
4
Biomolecular Reaction and Interaction Dynamics Global Environment (BRIDGE).生物分子反应和相互作用动力学全球环境(BRIDGE)。
Bioinformatics. 2019 Sep 15;35(18):3508-3509. doi: 10.1093/bioinformatics/btz107.
5
CHARMM-GUI Glycan Modeler for modeling and simulation of carbohydrates and glycoconjugates.CHARMM-GUI 聚糖建模器,用于碳水化合物和糖缀合物的建模和模拟。
Glycobiology. 2019 Apr 1;29(4):320-331. doi: 10.1093/glycob/cwz003.
6
TTClust: A Versatile Molecular Simulation Trajectory Clustering Program with Graphical Summaries.TTClust:一个功能多样的分子模拟轨迹聚类程序,带有图形摘要。
J Chem Inf Model. 2018 Nov 26;58(11):2178-2182. doi: 10.1021/acs.jcim.8b00512. Epub 2018 Oct 30.
7
The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update.Galaxy 平台:用于可访问、可重复和协作的生物医学分析:2018 年更新。
Nucleic Acids Res. 2018 Jul 2;46(W1):W537-W544. doi: 10.1093/nar/gky379.
8
doGlycans-Tools for Preparing Carbohydrate Structures for Atomistic Simulations of Glycoproteins, Glycolipids, and Carbohydrate Polymers for GROMACS.doGlycans——用于为糖蛋白、糖脂和碳水化合物聚合物的原子模拟准备碳水化合物结构的工具,适用于GROMACS。
J Chem Inf Model. 2017 Oct 23;57(10):2401-2406. doi: 10.1021/acs.jcim.7b00237. Epub 2017 Oct 12.
9
OpenMM 7: Rapid development of high performance algorithms for molecular dynamics.OpenMM 7:分子动力学高性能算法的快速开发。
PLoS Comput Biol. 2017 Jul 26;13(7):e1005659. doi: 10.1371/journal.pcbi.1005659. eCollection 2017 Jul.
10
Glycan Reader is improved to recognize most sugar types and chemical modifications in the Protein Data Bank.糖链阅读器得到了改进,能够识别蛋白质数据库中大多数糖类型和化学修饰。
Bioinformatics. 2017 Oct 1;33(19):3051-3057. doi: 10.1093/bioinformatics/btx358.